While cytokine inhibitors such as pentoxifylline and non-steroidal anti-inflammatory drugs have shown promise in reducing vasculitis severity through TNF-α suppression [37], and feline TNF-α-neutralizing monoclonal antibodies have been investigated [38], these immune-suppressing approaches alone have not proven effective in treating FIP. The gene discussed is TNF; the disease is vasculitis.